Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLARA: Tirzepatide and Letrozole in Early Breast Cancer
NCT07676331Phase 2Not yet recruiting
- Sponsor
- UZ Leuven
- Start
- Aug 2026
- Primary completion
- Mar 2028
01
Overview
A Phase 2 trial of tirzepatide in breast cancer, sponsored by UZ Leuven. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07676331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07676331.